No results were found for your search. Please adjust your search term or broaden your search criteria.
Still can't find what you are looking for? We can prepare Custom Research for you.
Lemtrada is a brand name for alemtuzumab, a monoclonal antibody used to treat multiple sclerosis (MS). It is a type of central nervous system (CNS) drug, which are used to treat a variety of neurological conditions. Lemtrada is used to reduce the frequency of relapses in people with relapsing-remitting MS, and to slow the progression of disability. It is administered as an intravenous infusion over two or three days.
The Lemtrada market is made up of pharmaceutical companies that produce and market the drug. These companies are involved in research and development, manufacturing, and marketing of the drug. They also provide support services to healthcare professionals and patients.
Some companies in the Lemtrada market include Sanofi, Bayer, Biogen, Merck, and Novartis. Show Less Read more
